XML 67 R10.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets

3 Months Ended

Dec. 31, 2012

5. Goodwill and Intangible Assets

The change in the carrying amount of goodwill by segment for the three months ended December 31, 2012 is as follows:

	Wholesale			European Retail		Puritan's Pride			Vitamin World		Consolidated

Balance at September 30, 2012	$	613,561		$	281,025	$	317,985		$	7,744	$	1,220,315
Acquisitions		33,190			—		—			—		33,190
Reassignment of goodwill(1)		—			35,000		(53,000	)		18,000		—
Foreign currency translation		(731	)		3,145		—			—		2,414

Balance at December 31, 2012	$	646,020		$	319,170	$	264,985		$	25,744	$	1,255,919

(1): Goodwill was reassigned based on the relative fair values of the elements transferred and the elements remaining in the respective segment. (See Note 12)

The carrying amounts of acquired other intangible assets for the periods indicated are as follows:

	December 31, 2012				September 30, 2012

	Gross carrying amount		Accumulated amortization		Gross carrying amount		Accumulated amortization
Definite lived intangible assets:
Brands and customer relationships	$	915,757	$	86,608	$	885,866	$	76,893
Tradenames and other		181,342		12,121		151,745		10,686

		1,097,099		98,729		1,037,611		87,579
Indefinite lived intangible assets:
Tradenames		1,002,248		—		1,001,772		—

Total intangible assets	$	2,099,347	$	98,729	$	2,039,383	$	87,579

Aggregate amortization expense of definite lived intangible assets included in the consolidated statements of income in selling, general and administrative expenses in the three months ended December 31, 2012, and 2011 was approximately $11,101 and $11,022, respectively.

Assuming no changes in our intangible assets, estimated amortization expense for each of the five succeeding years will be approximately $46,000 per year.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details